Status:
UNKNOWN
Efficacy and Outcomes of Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy Performed by Optometrists
Lead Sponsor:
Northeastern State University
Conditions:
Posterior Capsule Opacification Obscuring Vision
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to formally assess the efficacy and outcomes of optometrist-performed neodymium-doped yttrium aluminum garnet (Nd: YAG) laser capsulotomy procedures.
Detailed Description
Participants will undergo a pre-procedure examination to establish baseline findings and to determine if they meet the inclusion criteria. Participants will undergo the Nd: YAG laser capsulotomy proce...
Eligibility Criteria
Inclusion
- Ability to provide written informed consent;
- At least 18 years of age, male or female;
- Prior cataract surgery;
- Diagnosed with posterior capsule opacification obstructing vision;
- Best-corrected visual acuity less than 20/40 or visual acuity with glare that reduces by 2 lines or more on an ETDRS visual acuity chart or significant effect on activities of daily living
Exclusion
- History of underlying ocular disease (not including mild/moderate non-proliferative diabetic retinopathy or incidental findings)
- Previous myopic refractive error greater than 6.00 diopters
- Complications following previous ocular procedures (i.e. intraocular lens decentration)
- Ocular surgery other than uncomplicated cataract or uncomplicated refractive surgery
Key Trial Info
Start Date :
September 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04027595
Start Date
September 17 2019
End Date
September 30 2022
Last Update
September 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northeastern State University
Tahlequah, Oklahoma, United States, 74464